References
- Lee, C. H., Lee, H. K., Park, K. K., Park, C. H., Lee, B. Y., Sung, R. S. and Lee, S. H. (2002) Use of Resources a Plant for Biotechnology Industry development. Research Center for Bioresource and Health at Chungbuk National University
- Kim, S. J., Park, J. H., Choi, S. Y., Son, K. H. and Kim, K. U. (2007) Isolated and identification of biological activity compounds from leaves and stem of Paeonia lactiflora Pallas. Korean Journal of Medicinal Crop Science. 15: 6-11
- Lee, S. R., Lee, J. I. and Jung, K. J. (2004) Anticancer Medical Herbs of Korea. Jinsol Publishing company
- Lee, K. H., Cho, C. H. and Yoon, W. H. (2004) In vivo antitumor activity of mansonone E isolated from Ulmus davidiana var. japonica NAKAI. Korean Journal of Pharmacognosy. 35: 199-202
- Lim, S. Y. (2007) Effect of extracts from root bark of Ulmus parvifolia on inhibition of growth and DNA synthesis of human cancer cells. Journal of Life Science. 17: 1232-1236 https://doi.org/10.5352/JLS.2007.17.9.1232
- Park, S. J., Yoo, H. J., Choi, H. S., Seo, B. Y., Yang, S. H., Kim, Y. H., Jeong, J. Y. and Lee, K. N. (2004) Effects of Saururus chinensis Bail extracts on anticancer activity and cadmium induced cytotoxicity. The Korean Journal of Oriental Preventive Medicine. 8: 81-98
- Kwon, Y. M., Lee, J. H. and Lee, M. W. (2002) Phenolic compounds from barks of Ulmus macrocarpa and its antitoxidative activities. Korean Journal of Pharmacognosy. 33: 404-410
- Hu, W. and Kavanagh, J. J. (2003) Anticancer therapy targeting the apoptotic pathway. The Lancet Oncologyol. 4: 721-729 https://doi.org/10.1016/S1470-2045(03)01277-4
- Kaufmann, S. H. and Vaux, D. L. (2003) Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene. 22: 7414-7430 https://doi.org/10.1038/sj.onc.1206945
- Fulda, S. and Debatin, K. (2004) Exploiting death receptor signaling pathways for tumor therapy. Biochimica et Biophysica Acta, CR. Reviews on Cancer. 1705: 27-41 https://doi.org/10.1016/j.bbcan.2004.09.003
- Pisano, M., Pagnan, G., Loi, M., Mura, M. E, Tilocca, M. G., Palmieri, G., Fabbri, D., Dettori, M. A., Delogu, G., Ponzoni, M. and Rozzo, C. (2007) Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Molecular Cancer. 6: 8-19 https://doi.org/10.1186/1476-4598-6-8
- LeBlanc, H. N. and Ashkaenazi, A. (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death and Differentiation. 10: 66-75 https://doi.org/10.1038/sj.cdd.4401187
- Baetu, T. M. and Hiscott, J. (2002) On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 13: 199-207 https://doi.org/10.1016/S1359-6101(02)00006-0
- Trauzold, A., Wermann, H., Arlt, A., Schutze, S., Schafer, H., Oestern, S., Roder, C., Ungefroren, H., Lampe, E., Heinrich, M., Walczak, H. and Kalthoff, H. (2001) CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene. 20: 4258-4269 https://doi.org/10.1038/sj.onc.1204559
- Jaattela, M. (2002) Programmed cell death: many ways for cells to die decently. Annals of Medicine. 34: 480-488 https://doi.org/10.1080/078538902321012423
- Reed, J. C. (2002) Apoptosis-based therapies. Nature Reviews. Drug Discovery. 1: 111-121 https://doi.org/10.1038/nrd726
- Ku, J. L. and Park, J. G. (2005). Biology of SNU cell lines. Cancer Research and Treatment. 37: 1-19 https://doi.org/10.4143/crt.2005.37.1.1